| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Revenue: | ||||||||
Total revenue | ||||||||
7,171 | 6,001 | 2,696 | 6,917 | 5,605 | 9,145 | 6,503 | 7,109 | 4,751 |
Grant revenue | ||||||||
- | - | - | - | - | 0 | 0 | 0 | 169 |
Total revenue | ||||||||
- | - | 2,696 | 6,917 | - | 9,145 | 6,503 | 7,109 | 4,920 |
Operating expenses: | ||||||||
Research and development | ||||||||
34,605 | 25,762 | 28,519 | 25,640 | 20,607 | 24,097 | 20,392 | 16,818 | 11,724 |
General and administrative | ||||||||
14,644 | 12,581 | 8,326 | 8,429 | 5,759 | 4,065 | 2,926 | 2,522 | 2,421 |
Total operating expenses | ||||||||
49,249 | 38,343 | 36,845 | 34,069 | 26,366 | 28,162 | 23,318 | 19,340 | 14,145 |
Loss from operations | ||||||||
-42,078 | -32,342 | -34,149 | -27,152 | -20,761 | -19,017 | -16,815 | -12,231 | -9,225 |
Other income, net | ||||||||
2,059 | 1,815 | 2,411 | 2,592 | 2,201 | 1,644 | 1,498 | 1,110 | 788 |
Net loss | ||||||||
-40,019 | -30,527 | -31,738 | -24,560 | -18,560 | -17,373 | -15,317 | -11,121 | -8,437 |
Unrealized gain on marketable securities | ||||||||
2,640 | -84 | -215 | 333 | 150 | 98 | -48 | 62 | -154 |
Comprehensive loss | ||||||||
-37,379 | -30,611 | -31,953 | -24,227 | -18,410 | -17,275 | -15,365 | -11,059 | -8,591 |
Net loss per share, basic and diluted | ||||||||
-0.53 | -0.46 | -0.47 | -0.36 | -0.42 | -1.50 | -1.34 | -1.00 | -0.78 |
Shares used in computing net loss per share, basic and diluted | ||||||||
74,820 | 68,209 | 67,572 | 67,327 | 43,828 | 11,754 | 11,441 | 11,157 | 10,858 |